Tolerance and pharmacokinetics of pitolisant (Wakix®), a histamine H3 antagonist, in 24 narcoleptic children

被引：0
|
作者：
Lecendreux, M. [1 ]
Plazzi, G. [2 ]
Franco, P. [3 ]
Robert, P. [4 ]
Duvauchelle, T. [5 ]
Lecomte, J. -M. [5 ]
机构：
[1] Robert Debre Univ Hosp, Clin Invest Ctr, Paris, France
[2] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Alma Mater Studiorum, Bologna, Italy
[3] Univ Hosp, Pediat Sleep Dept, Lyon, France
[4] Bioprojet Biotech, St Gregoire, France
[5] Bioprojet, Paris, France
来源：
JOURNAL OF SLEEP RESEARCH | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P442
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [1] TOLERANCE AND PHARMACOKINETICS OF PITOLISANT (WAKIX®), A HISTAMINE H3 ANTAGONIST, IN 24 NARCOLEPTIC CHILDREN
    Lecendreux, M.
    Plazzi, G.
    Franco, P.
    Robert, P.
    Duvauchelle, T.
    Lecomte, J. -M.
    SLEEP MEDICINE, 2017, 40 : E182 - E182
  • [2] LONG-TERM EVALUATION OF SAFETY AND EFFICACY OF PITOLISANT (WAKIX®), AN HISTAMINE H3R ANTAGONIST, IN NARCOLEPSY
    Dauvilliers, Y.
    Arnulf, I.
    Szakacs, Z.
    Scart-Gres, C.
    Lecomte, I.
    Causse, C.
    Schwartz, J-C.
    SLEEP MEDICINE, 2017, 40 : E75 - E75
  • [3] ANTICATAPLECTIC EFFICACY OF WAKIX® (PITOLISANT), THE FIRST POTENT AND HIGHLY SELECTIVE HISTAMINE H3-RECEPTOR ANTAGONIST/INVERSE AGONIST IN CLINICS
    Schwartz, J. -C.
    Lecomte, J. -M.
    Causse, C.
    SLEEP MEDICINE, 2017, 40 : E297 - E297
  • [4] H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice
    Magdalena Dudek
    Kamil Kuder
    Marcin Kołaczkowski
    Adrian Olczyk
    Elżbieta Żmudzka
    Aleksandra Rak
    Marek Bednarski
    Karolina Pytka
    Jacek Sapa
    Katarzyna Kieć-Kononowicz
    Metabolic Brain Disease, 2016, 31 : 1023 - 1029
  • [5] H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice
    Dudek, Magdalena
    Kuder, Kamil
    Kolaczkowski, Marcin
    Olczyk, Adrian
    Zmudzka, Elzbieta
    Rak, Aleksandra
    Bednarski, Marek
    Pytka, Karolina
    Sapa, Jacek
    Kiec-Kononowicz, Katarzyna
    METABOLIC BRAIN DISEASE, 2016, 31 (05) : 1023 - 1029
  • [6] Wake promoting effects of thioperamide, a histamine H3 antagonist in orexin/ataxin-3 narcoleptic mice
    Shiba, T
    Fujiki, N
    Wisor, JP
    Dale, EM
    Sakurai, T
    Nishino, S
    SLEEP, 2004, 27 : 241 - 242
  • [7] The histamine H3 receptor: from discovery to clinical trials with pitolisant
    Schwartz, Jean-Charles
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (04) : 713 - 721
  • [8] Role of Histamine H3 Receptor Antagonist Pitolisant in Early Neural Differentiation of Mouse Embryonic Stem Cells
    Xu, Genghua
    Liu, Nuoya
    Qiu, Yaqing
    Qi, Jiayu
    Zhu, Danyan
    STEM CELLS AND DEVELOPMENT, 2024, 33 (3-4) : 67 - 78
  • [9] Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil
    Uguen, M.
    Perrin, D.
    Belliard, S.
    Ligneau, X.
    Beardsley, P. M.
    Lecomte, J. M.
    Schwartz, J. C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (03) : 632 - 644
  • [10] Exploring occupancy of the histamine H3 receptor by pitolisant in humans using PET
    Rusjan, Pablo
    Sabioni, Pamela
    Di Ciano, Patricia
    Mansouri, Esmaeil
    Boileau, Isabelle
    Layeille, Alexia
    Capet, Marc
    Duvauchelle, Thierry
    Schwartz, Jean-Charles
    Robert, Philippe
    Le Foll, Bernard
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (15) : 3464 - 3472
12345